Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for albicans and non-albicans candidemia in the intensive care unit*

(2009) Jennifer K. Chow et al.   CRITICAL CARE MEDICINE

Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.

(2009) E Geoffrey Playford et al.   CRITICAL CARE MEDICINE

Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care Unit

(2008) Jennifer K. Chow et al.   CLINICAL INFECTIOUS DISEASES

Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies

(2008) Elizabeth Johnson et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: An analysis of microbiological data

(2008) George Samonis et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

(2007) Michael J. Klevay et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE